PT3446684T - Comprimido orodispersível - Google Patents

Comprimido orodispersível

Info

Publication number
PT3446684T
PT3446684T PT178133856T PT17813385T PT3446684T PT 3446684 T PT3446684 T PT 3446684T PT 178133856 T PT178133856 T PT 178133856T PT 17813385 T PT17813385 T PT 17813385T PT 3446684 T PT3446684 T PT 3446684T
Authority
PT
Portugal
Prior art keywords
orally disintegrating
disintegrating tablet
tablet
orally
disintegrating
Prior art date
Application number
PT178133856T
Other languages
English (en)
Original Assignee
Towa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Towa Pharmaceutical Co Ltd filed Critical Towa Pharmaceutical Co Ltd
Publication of PT3446684T publication Critical patent/PT3446684T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT178133856T 2016-06-16 2017-06-15 Comprimido orodispersível PT3446684T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016120056 2016-06-16

Publications (1)

Publication Number Publication Date
PT3446684T true PT3446684T (pt) 2021-12-16

Family

ID=60663425

Family Applications (1)

Application Number Title Priority Date Filing Date
PT178133856T PT3446684T (pt) 2016-06-16 2017-06-15 Comprimido orodispersível

Country Status (6)

Country Link
US (1) US20190328674A1 (pt)
EP (1) EP3446684B1 (pt)
JP (1) JP6496084B2 (pt)
ES (1) ES2900566T3 (pt)
PT (1) PT3446684T (pt)
WO (1) WO2017217491A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6504638B1 (ja) * 2018-05-31 2019-04-24 武田テバファーマ株式会社 錠剤及びその製造方法
JP7134048B2 (ja) * 2018-09-28 2022-09-09 ホソカワミクロン株式会社 測定評価装置及びそれによる評価方法
WO2020246120A1 (ja) * 2019-06-07 2020-12-10 あゆみ製薬株式会社 口腔内崩壊錠及びその製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1161941A4 (en) * 1999-03-15 2002-08-28 Kaken Pharma Co Ltd FAST DELITING TABLETS AND MANUFACTURING METHOD
EP1203580A4 (en) * 1999-06-18 2004-06-30 Takeda Chemical Industries Ltd SOLID PREPARATIONS WITH FAST DISINTEGRATION
AU2001267865A1 (en) * 2000-06-30 2002-01-14 Yamanouchi Pharmaceutical Co..Ltd. Tablet rapidly disintegrating in mouth and process for producing the same
GB0204771D0 (en) * 2002-02-28 2002-04-17 Phoqus Ltd Fast disintegrating tablets
US20100233278A1 (en) * 2007-09-27 2010-09-16 Akiko Ookawa Rapidly disintegrating solid preparation
US10195154B2 (en) * 2011-06-10 2019-02-05 Nipro Corporation Method for producing orodispersible tablets
EP2810659B1 (en) * 2012-02-03 2017-08-09 Asahi Kasei Kabushiki Kaisha Orally disintegrating tablet containing bitterness-masking granules
IN2014DN10076A (pt) * 2012-05-31 2015-08-21 Asahi Kasei Chemicals Corp
JP2015218322A (ja) * 2014-05-21 2015-12-07 旭化成ケミカルズ株式会社 微小澱粉粒子及びその製造方法

Also Published As

Publication number Publication date
EP3446684A4 (en) 2019-06-19
EP3446684A1 (en) 2019-02-27
WO2017217491A1 (ja) 2017-12-21
ES2900566T3 (es) 2022-03-17
JP6496084B2 (ja) 2019-04-03
US20190328674A1 (en) 2019-10-31
EP3446684B1 (en) 2021-11-17
JPWO2017217491A1 (ja) 2019-04-04

Similar Documents

Publication Publication Date Title
AU356804S (en) Tablet
IL262312A (en) Disintegrating tablets for oral administration
ZAA201800547S (en) Tablets
IL254818A0 (en) Ribociclib tablet
HK1232170A1 (zh) 速效口溶膜劑
GB2543579B (en) Pivoting tablet die
EP3549585A4 (en) TABLET WITHIN A DIAMOND DERIVATIVES IN THE MOUTH
EP3449912A4 (en) ORODISPERSIBLE TABLET
HK1249857A1 (zh) 片劑
GB201420300D0 (en) Tablet
EP3328360A4 (en) Tofacitinib orally disintegrating tablets
PL3257511T3 (pl) Tabletka rozpadająca się w jamie ustnej i sposób jej wytwarzania
HK1220139A1 (zh) 口腔崩解片
PT3446684T (pt) Comprimido orodispersível
PL3174533T3 (pl) Tabletka ulegająca rozpadowi w jamie ustnej
PT3116517T (pt) Comprimido vaginal mucoadesivo de libertação prolongada
IL255048A0 (en) The compositions that disintegrate in the mouth
EP3733166A4 (en) ORAL DISINTEGRATION CYCLIC TABLET
AU356801S (en) Tablet
EP3431079C0 (en) COMPRESSED
GB201511252D0 (en) Tablet
TWM532873U (en) Tablet structure
GB201600998D0 (en) Fastened tablet stand
GB2526075B (en) Macerator wall channels
AU356805S (en) Tablet